PAR 3.70% 28.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1736

  1. 471 Posts.
    lightbulb Created with Sketch. 209
    Coppo's report today (Mon 21/06/2021) on the approvals for Phase 2 clinical trial treating MPS-VI subjects in Brazil with PPS announced on Friday from the great man himself Richard Coppleson who is also a loyal LT SH too! wink.png

    https://hotcopper.com.au/data/attachments/3288/3288134-53e11b8d40a0ddd264966a500336d822.jpg
    GLTA LTSHs & PLS DYOR!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
0.010(3.70%)
Mkt cap ! $94.44M
Open High Low Value Volume
27.0¢ 29.0¢ 27.0¢ $115.5K 412.2K

Buyers (Bids)

No. Vol. Price($)
3 30909 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 9752 5
View Market Depth
Last trade - 11.50am 14/05/2024 (20 minute delay) ?
Last
28.0¢
  Change
0.010 ( 3.70 %)
Open High Low Volume
27.5¢ 29.0¢ 27.5¢ 31336
Last updated 12.26pm 14/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.